Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Genky DrugStores Co., Ltd. ( (JP:9267) ) has issued an announcement.
Genky DrugStores reported continued top-line and profit growth through FY2025 and into FY2026, supported by steady same-store sales increases, disciplined cost control, and an expanding store network. The company plans to accelerate new store openings to 66 outlets in FY2026 while keeping closures and renovations limited, lifting total stores toward the mid-500s and sustaining year-on-year revenue growth of around high single digits. Profitability metrics remain robust, with operating and ordinary profit margins hovering around 4.7–5.0%, rising EBITDA and net assets, and improving ROE and equity ratio, indicating a solid financial base despite negative free cash flow due to elevated capital expenditure for expansion. Per-share indicators, adjusted for a recent stock split, show rising earnings and book value alongside a modest, gradually increasing dividend, suggesting management is prioritizing reinvestment-led growth while maintaining shareholder returns at a conservative payout ratio.
The most recent analyst rating on (JP:9267) stock is a Buy with a Yen4934.00 price target. To see the full list of analyst forecasts on Genky DrugStores Co., Ltd. stock, see the JP:9267 Stock Forecast page.
More about Genky DrugStores Co., Ltd.
Genky DrugStores Co., Ltd. operates a drugstore chain focused on everyday low-price retailing of pharmaceuticals, daily necessities, and food products, primarily in Japan’s Hokuriku and Chubu regions including Fukui, Ishikawa, Gifu, Aichi and Shiga prefectures. The company has pursued an aggressive store-opening strategy and operates large-format stores with relatively high sales and profitability per unit floor area, positioning itself as a growth-oriented regional discount drugstore player.
Average Trading Volume: 95,093
Technical Sentiment Signal: Buy
Current Market Cap: Yen138.2B
For a thorough assessment of 9267 stock, go to TipRanks’ Stock Analysis page.

